ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008

Memphis CCOP Withdrawn, Says Lack Of Patient Benefits, Excess Tests Discouraged Local Physicians

November 16, 1984

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008